4Sikic BI,Fisher GA,Lure BL,et a1.Modulation and prevention of muhidrug resistance by inhibitors of P-glyeoprotein.Cancer Chemother Pharmacol,1997,140:1113～1119.
5Filipits M,Suchomel RW,Dekan G,et a1.MRP and MDRl gene expression in primary breast carcinomas.Clin Cancer Res,1996,2:1231～1237.
6Volm M, Kastel M, Mttern J, et al. Expression of resistance factors (P-glycoprotein, Glutathione S-Transferase π,and Topoisomerase I) and their interrelationship to proto-oncogene productsion renal cell carcinoma. Cancer, 1993, 71: 3981.
7Cucco C, Calabretta B. In vitro and vivo reversal of multidrug resistance in a human leukemia-resisitant cell line by MDR1 antisense oligodeoxynucleotides. Cancer Res, 1996, 56: 4332.
8Stein U, Walther W, Shoemaker RH. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells. Natl Cancer Inst, 1996, 88: 1383.
9Sinha BK, Yamazaki H, Eliot HM, et al. Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells. Biochim Biophys Acta, 1995,1270: 12.
10Biedler JL, Riehm H. Cellular resistance to actionmycin in chinese hamster cells in vitro:cross-resistance radioautographic and cytogenetic studies. Cancer Res, 1970, 30: 1174-1184.
